Hassanein Waleed H's Form 4 filing
TransMedics Group, Inc. (TMDX) · filed Aug 8, 2025
- Accession no.
- 0000950170-25-105907
- Filed
- Aug 8, 2025
- Trade date
- Aug 6-7, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.98M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hassanein Waleed HCIK 0001430466 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | Common Stock | PPurchaseAcquired | +8,400 | $118.68 | +$996,912 | 477,759 | Indirect | |
| Aug 7, 2025 | Common Stock | PPurchaseAcquired | +6,617 | $116.08 | +$768,101.36 | 484,376 | Indirect | |
| Aug 7, 2025 | Common Stock | PPurchaseAcquired | +1,858 | $116.85 | +$217,107.3 | 486,234 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.